MEI Pharma, Inc.
MEIPNASDAQHealthcare
$3.07
+$0.29(+10.43%)
Market Cap$20452012
P/E Ratio—
52W High$9
52W Low$1.46
MEI Pharma, Inc.（MEIP）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MEIP · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.02B) | $0.02B | ($0.03B) | ($0.05B) | ($0.05B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | ($0.00B) | $0.00B | $0.00B | $0.01B | $0.01B |
| Change in Working Capital | ($0.00B) | ($0.08B) | ($0.02B) | $0.02B | $0.03B |
| Net Cash from Operations | ($0.02B) | ($0.05B) | ($0.05B) | ($0.05B) | ($0.03B) |
| Investing Activities | |||||
| Capital Expenditure | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | ($0.06B) | ($0.10B) | ($0.27B) | ($0.42B) |
| Sales of Investments | $0.03B | $0.11B | $0.16B | $0.28B | $0.45B |
| Net Cash from Investing | $0.04B | $0.05B | $0.05B | $0.01B | $0.02B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Dividends Paid | $0.00B | ($0.01B) | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.00B | ($0.01B) | ($0.00B) | $0.05B | $0.00B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.02B) | ($0.05B) | ($0.05B) | ($0.05B) | ($0.03B) |
| FCF Margin %(computed) | — | -77.31% | -107.59% | -120.95% | -127.95% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解MEI Pharma, Inc.
关于MEI Pharma, Inc.（MEIP）现金流量表
MEI Pharma, Inc. 2025财年经营活动现金流($0.02B)，自由现金流($0.02B)（FCF利润率—），资本支出$0.00B。
常见问题
MEIP · 4 问MEI Pharma, Inc. 2025财年自由现金流($0.02B)，同比up58.7%。
MEIP free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10